Datacubed Health, a provider of patient engagement and data collection technology for clinical trials, has launched its eClinical platform app in China. The company has joined forces with AppInChina, a specialist in Android App Store publication. This will support deployment of the eClinical platform app in official Android stores across China and the Apple App Store. The partnership provides accessibility to a range of devices and ecosystems.

Datacubed Health has established a legal entity within China and acquired commercial and legal licenses and certificates.

The company is ensuring software compliance with Chinese regulations, with the eClinical platform app for China customised for local requirements and undergoing testing by local quality assurance teams.

Datacubed Health has also bolstered its presence in China by establishing a compliant, fault-tolerant Software as a Service (SaaS) infrastructure hosted by AWS Beijing.

Kyle Hogan, President of Datacubed Health, said: “Our partnership with AppInChina has been instrumental in ensuring the smooth launch of our eClinical platform app in China. This strategic alliance allows us to reach a broader audience while maintaining compliance with local regulations, which is essential for our growth in this market.”

Brett Kleger, CEO of Datacubed Health, stated, “Our investment in establishing a legal presence and obtaining the requisite licenses underscores our dedication to operating ethically and responsibly in China. We are focused on delivering cutting-edge solutions while adhering to local regulations and standards.”